This inventor holds 58 USPTO granted patents and 24 published patent applications, plus 9 CIPO patents and 28 EPO patents, primarily in Viral Therapeutics. Top assignees: Xiamen University, Xiamen Innovax Biotech Co., Ltd., Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.. Active years: 2009-2026.
Location History:
- Hangzhou, CN (2013 - 2014)
- Fujian Province, CN (2018 - 2022)
- Fujian, CN (2009 - 2023)
- Xiamen, CN (2010 - 2023)
Company Filing History:
56 out of 165 
23 out of 23 
15 out of 15 
Years Active: 2009-2026
Areas of Expertise:
Title: Ningshao Xia: A Pioneer in HPV Research and Tumor Treatment
Introduction
Ningshao Xia is a notable inventor based in Xiamen, China, recognized for his significant contributions to the fields of virology and vaccine development. With an impressive portfolio of 50 patents, Xia's work focuses on innovative solutions for preventing human papillomavirus (HPV) infections and treating tumors.
Latest Patents
Ningshao Xia’s latest patents include a groundbreaking innovation related to human papilloma virus type 51 L1 protein mutants. This invention provides a mutated HPV51 L1 protein or its variants, along with a coding sequence and a method of preparation. The virus-like particle formed by this protein is capable of inducing neutralizing antibodies against different types of HPV, such as HPV51 and HPV69. Additionally, the invention covers the use of this protein and the associated virus-like particle in creating pharmaceutical compositions or vaccines aiming to prevent infections from at least two types of HPV and associated diseases, including cervical cancer and condyloma acuminatum.
Another significant patent by Xia pertains to the use of enterovirus D68 (EV-D68) for tumor treatment. This patent presents various forms of the virus or a nucleic acid molecule that includes the genomic sequence or cDNA of EV-D68. The invention also addresses pharmaceutical compositions aimed at utilizing EV-D68 for effective tumor treatment.
Career Highlights
Ningshao Xia has collaborated with esteemed institutions, including Xiamen University and Xiamen Innovax Biotech Co., Ltd. His time at these organizations has fostered an environment rich in innovation, leading to numerous patents that reflect his commitment to advancing medical science.
Collaborations
Throughout his career, Xia has worked alongside talented individuals such as Jun Zhang and Shaowei Li. Their collective efforts have undoubtedly propelled advancements in research and development, allowing them to address complex health challenges through innovative solutions.
Conclusion
Ningshao Xia stands out as an influential inventor whose work significantly impacts public health. His recent patents in HPV and tumor treatment illustrate the importance of innovation in combating diseases and highlight his dedication to improving lives through scientific progress.